- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT03564184
Longitudinal Study of Music Therapy's Effectiveness for Premature Infants and Their Caregivers (LongSTEP)
Longitudinal Study of Music Therapy's Effectiveness for Premature Infants and Their Caregivers: International Randomized Trial
Background: Preterm birth has major medical, psychological and socio-economic consequences worldwide. A recent systematic review suggests positive effects of music therapy (MT) on physiological measures of preterm infants and maternal anxiety, but methodologically rigorous studies including long-term follow-up of infant and parental outcomes are missing. Drawing upon caregivers' inherent resources, this study emphasizes caregiver involvement in MT to promote attuned, developmentally-appropriate musical interactions that may be of mutual benefit to infant and parent. This study will determine whether MT, as delivered by a qualified music therapist during neonatal intensive care unit (NICU) hospitalization and/or in home/municipal settings following discharge, is superior to standard care in improving bonding between primary caregivers and preterm infants, parent well-being and infant development.
Methods: Design: International multi-center, assessor-blind, 2x2 factorial, pragmatic randomized controlled trial. A feasibility study has been completed; ethical approval for the main trial is pending. Participants: 250 preterm infants and their parents. Intervention: MT focusing on singing specifically tailored to infant responses, will be delivered during NICU and/or during a post-discharge 6-month period. Primary outcome: Changes in mother-infant bonding until 6 months corrected age (CA), as measured by the Postpartum Bonding Questionnaire. Secondary outcomes: Mother-infant bonding at discharge and over 12 months CA; child development over 24 months; and parental depression, anxiety, and stress, and infant re-hospitalization, all over 12 months.
Discussion: This study fills a gap by measuring the long-term impact of MT for preterm infants/caregivers, and of MT beyond the hospital context. Outcomes related to highly involving parents in MT will directly inform the development of clinical practice in Scandinavia and other contexts with similar social welfare practices. By incorporating family-centered care, continuity of care, user involvement, and cultural relevance, this study can potentially contribute to improved quality of care for premature infants and their parents worldwide.
Study Overview
Status
Conditions
Intervention / Treatment
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
-
Buenos Aires, Argentina
- Hospital Fernandez
-
-
Caba
-
Buenos Aires, Caba, Argentina, 1246
- Hospital Materno Infantil Ramón Sardá
-
Buenos Aires, Caba, Argentina, C1425DND
- Sanatorio Mater Dei
-
-
-
-
-
Bogotá, Colombia
- Fundacion Santa Fe de Bogota
-
Bogotá, Colombia
- Clinica de la Mujer
-
-
-
-
-
Kfar Saba, Israel, 4428164
- Meir Medical Center
-
-
-
-
-
Oslo, Norway, 0424
- Oslo University Hospital, Rikshospitalet
-
-
Hordaland
-
Bergen, Hordaland, Norway, 5006
- Haukeland University Hospital, Barne-og ungdomsklinikken
-
-
Lørenskog
-
Oslo, Lørenskog, Norway, 1478
- Akershus University Hospital
-
-
-
-
-
Ruda Śląska, Poland, 41-703
- Szpital Miejski w Rudzie Śląskiej
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
- ADULT
- OLDER_ADULT
- CHILD
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria (infants):
- born below 35 weeks gestational age
- determined by medical staff to have achieved sufficient medical stability to start MT
- likely to be hospitalized longer than 2 weeks from time of recruitment
Inclusion Criteria (parents):
- willing to engage in at least 2 of 3 MT sessions per week during NICU and/or in 5 of 7 MT post-discharge sessions, if randomized to receive MT
- live with reasonable commuting distance from the treating NICU
- sufficient understanding of the respective national language(s) to answer questionnaires and participate in MT
Exclusion Criteria (parents):
- documented mental illness or cognitive impairment that prevents them from being able to complete the study intervention or outcome assessments
Study Plan
How is the study designed?
Design Details
- Primary Purpose: TREATMENT
- Allocation: RANDOMIZED
- Interventional Model: FACTORIAL
- Masking: SINGLE
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
EXPERIMENTAL: MT during and after NICU
Consists of music therapy during NICU hospitalization, and music therapy after discharge from initial NICU hospitalization, along with standard care.
|
Music therapy (MT) by trained music therapist, 3 times/week for 30-40 minutes/session during NICU hospitalization.
Involves primary caregiver and infant in musical communication matched to infant post-menstrual age, family/cultural preferences, and infant readiness for stimulation.
Music therapist assesses infant´s needs and behavior state, supports caregiver in using basic touch (e.g., hand lightly and statically on infant´s chest or back to perceive breathing pattern) and caregiver´s hummed/sung voice matched to infant behavioral responses, to promote infant state regulation and bonding.
Music includes input from music therapist as needed, and multimodal aspects such as gentle dynamic touch when infant demonstrates readiness.
MT may occur while infant is held in a static manner by caregiver or is resting in his/her isolette or basinet.
MT may occur during skin-to-skin care, if such care is part of standard care.
Music therapy offered by trained music therapist, 7 times for approximately 45 minutes/session across first 6 months following discharge from initial NICU hospitalization.
Sessions include infant and caregiver, and siblings, if desired, and occur at home or in municipal settings.
MT after NICU consists of a consult-to-parent model with each session including a brief verbal check-in regarding infant´s progress, musical interactions with music therapist modelling musical engagement, discussion of current challenges and strategies for using musical interactions to address needs in areas such as infant self-regulation, parent/infant interaction, and challenges with bonding.
Caregivers will demonstrate techniques discussed during session, and form a brief plan for use of musical interaction in the interim before next session.
Sessions will be adapted to infant developmental level and ongoing needs.
Includes necessary medical care and standard supportive interventions offered as part of care during hospitalization, and standard follow-up procedures post-hospitalization.
|
EXPERIMENTAL: MT during NICU
Consists of music therapy during NICU hospitalization, along with standard care.
|
Music therapy (MT) by trained music therapist, 3 times/week for 30-40 minutes/session during NICU hospitalization.
Involves primary caregiver and infant in musical communication matched to infant post-menstrual age, family/cultural preferences, and infant readiness for stimulation.
Music therapist assesses infant´s needs and behavior state, supports caregiver in using basic touch (e.g., hand lightly and statically on infant´s chest or back to perceive breathing pattern) and caregiver´s hummed/sung voice matched to infant behavioral responses, to promote infant state regulation and bonding.
Music includes input from music therapist as needed, and multimodal aspects such as gentle dynamic touch when infant demonstrates readiness.
MT may occur while infant is held in a static manner by caregiver or is resting in his/her isolette or basinet.
MT may occur during skin-to-skin care, if such care is part of standard care.
Includes necessary medical care and standard supportive interventions offered as part of care during hospitalization, and standard follow-up procedures post-hospitalization.
|
EXPERIMENTAL: MT after NICU
Consists of music therapy after discharge from initial NICU hospitalization, along with standard care.
|
Music therapy offered by trained music therapist, 7 times for approximately 45 minutes/session across first 6 months following discharge from initial NICU hospitalization.
Sessions include infant and caregiver, and siblings, if desired, and occur at home or in municipal settings.
MT after NICU consists of a consult-to-parent model with each session including a brief verbal check-in regarding infant´s progress, musical interactions with music therapist modelling musical engagement, discussion of current challenges and strategies for using musical interactions to address needs in areas such as infant self-regulation, parent/infant interaction, and challenges with bonding.
Caregivers will demonstrate techniques discussed during session, and form a brief plan for use of musical interaction in the interim before next session.
Sessions will be adapted to infant developmental level and ongoing needs.
Includes necessary medical care and standard supportive interventions offered as part of care during hospitalization, and standard follow-up procedures post-hospitalization.
|
EXPERIMENTAL: No MT
Consists of standard care.
|
Includes necessary medical care and standard supportive interventions offered as part of care during hospitalization, and standard follow-up procedures post-hospitalization.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Bonding between primary caregiver and infant
Time Frame: 6 months
|
Total score of the Postpartum Bonding Questionnaire (PBQ), a parent-rated screening instrument for disorders of the early mother-infant relationship consisting of 25 statements on a six-point Likert scale (each 0-5; sum score ranging from 0 to 125; high = problematic).
|
6 months
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Bonding between primary caregiver and infant
Time Frame: 12 months
|
Total score of the Postpartum Bonding Questionnaire (PBQ), a parent-rated screening instrument for disorders of the early mother-infant relationship consisting of 25 statements on a six-point Likert scale (each 0-5; sum score ranging from 0 to 125; high = problematic).
|
12 months
|
Child development
Time Frame: 24 months
|
Bayley Scales of Infant and Toddler Development, 3rd edition (Bayley-III), standardized with a population mean of 100 (SD 15), with higher scores indicating better development
|
24 months
|
Infant development
Time Frame: 12 months
|
Ages and Stages Questionnaire, 3rd edition (ASQ-3), an age-specific parent-reported screening questionnaire consisting of 30 items, total sum score ranging from 0 to 300, with higher scores indicating better development.
|
12 months
|
Infant socio-emotional development
Time Frame: 12 months
|
Ages and Stages Questionnaire Social-Emotional (ASQ:SE), a parent-completed questionnaire with 19 or 22 Likert-scaled items (each 0-5-10), plus additional items for whether an item is of concern to the parent (each 0-5), resulting in a score ranging from 0-285 or 0-300, at 6 and 12 months respectively.
Lower scores indicate better socio-emotional development.
|
12 months
|
Re-hospitalization
Time Frame: 12 months
|
Re-hospitalization excluding outpatient visits, based on electronic health records.
This will be calculated as the time from initial discharge until first re-hospitalization.
|
12 months
|
Maternal depression
Time Frame: 12 months
|
Edinburgh Postnatal Depression Scale (EPDS), a 10-item validated self-report instrument assessing mothers' postpartum depressive symptoms, excluding somatic symptoms of depression that are common in new mothers (such as loss of energy, feeling tired, changes in appetite and sexual drive).
Sum scores can range from 0 to 30, with high scores indicating more depressive symptoms.
|
12 months
|
Parental anxiety
Time Frame: 12 months
|
Generalized Anxiety Disorder Assessment (GAD-7), a self-report 7-item questionnaire serving as a screening tool and severity measure for generalized anxiety disorder.
Sum scores can range from 0 to 21, with higher scores indicating higher anxiety.
|
12 months
|
Parental stress
Time Frame: 12 months
|
Parental Stress Scale (PSS), a self-report 18-item questionnaire that assesses stress associated with parenting.
Sum scores can range from 18 to 90, with higher scores indicating higher stress.
|
12 months
|
Collaborators and Investigators
Collaborators
Investigators
- Study Chair: Christian Gold, PhD, NORCE Norwegian Research Centre
- Principal Investigator: Claire Ghetti, PhD, Grieg Academy, University of Bergen
Publications and helpful links
General Publications
- Bieleninik L, Ghetti C, Gold C. Music Therapy for Preterm Infants and Their Parents: A Meta-analysis. Pediatrics. 2016 Sep;138(3):e20160971. doi: 10.1542/peds.2016-0971. Epub 2016 Aug 25.
- Ghetti C, Bieleninik L, Hysing M, Kvestad I, Assmus J, Romeo R, Ettenberger M, Arnon S, Vederhus BJ, Soderstrom Gaden T, Gold C. Longitudinal Study of music Therapy's Effectiveness for Premature infants and their caregivers (LongSTEP): protocol for an international randomised trial. BMJ Open. 2019 Sep 3;9(8):e025062. doi: 10.1136/bmjopen-2018-025062.
- Gaden TS, Ghetti C, Kvestad I, Bieleninik L, Stordal AS, Assmus J, Arnon S, Elefant C, Epstein S, Ettenberger M, Lichtensztejn M, Lindvall MW, Mangersnes J, Roed CJ, Vederhus BJ, Gold C. Short-term Music Therapy for Families With Preterm Infants: A Randomized Trial. Pediatrics. 2022 Feb 1;149(2):e2021052797. doi: 10.1542/peds.2021-052797.
Helpful Links
Study record dates
Study Major Dates
Study Start (ACTUAL)
Primary Completion (ACTUAL)
Study Completion (ACTUAL)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (ACTUAL)
Study Record Updates
Last Update Posted (ACTUAL)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- RCN 273534
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
IPD Plan Description
IPD Sharing Supporting Information Type
- STUDY_PROTOCOL
- SAP
- ICF
- ANALYTIC_CODE
- CSR
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Preterm Birth
-
e-Bio CorpRecruitingPreterm Labor | PreTerm Birth | Preterm Labor With Delivery NosUnited States
-
Thomas Jefferson UniversityCompleted
-
Chelsea and Westminster NHS Foundation TrustSPD Development Company Limited; Borne CharityRecruitingPreterm Birth | Preterm Labor | Preterm Birth Complication | Preterm Premature Rupture of Membrane | Preterm PregnancyUnited Kingdom
-
Cairo UniversityCompleted
-
University of OklahomaCompletedPreTerm Birth | PreTerm NeonateUnited States
-
PreTeL, IncDuke University; University of RochesterRecruitingPreterm Birth | Threatened Preterm Labor | PreTerm LaborUnited States
-
Federico II UniversityRecruiting
-
University of OxfordShoklo Malaria Research UnitCompleted
-
Eunice Kennedy Shriver National Institute of Child...CompletedPregnancy | Preterm Birth | Preterm LaborUnited States
-
University Hospital Inselspital, BerneAmniSure International LLCCompletedPreterm Birth | Preterm LabourSwitzerland
Clinical Trials on MT during NICU
-
Northwell HealthEnrolling by invitationDischarge ReadinessUnited States
-
Children's Hospital Medical Center, CincinnatiRecruiting
-
Georgia State UniversityHealth Resources and Services Administration (HRSA)CompletedParenting | Infant Health | Intensive Care Units Neonatal
-
Kolding SygehusCompleted
-
Mitsubishi Tanabe Pharma CorporationCompletedDiabetic NephropathyJapan
-
Thrive Neuromedical, LLCEmory University; National Institute on Deafness and Other Communication Disorders...RecruitingPremature BirthUnited States
-
Mitsubishi Tanabe Pharma America Inc.CompletedMenopause Hot FlashesUnited States
-
Mitsubishi Tanabe Pharma America Inc.Terminated
-
Renrong WuCompleted
-
Mitsubishi Tanabe Pharma CorporationCompletedRelapsing-remitting Multiple SclerosisCroatia, Bulgaria, Czech Republic, Italy, Russian Federation, Spain, United Kingdom, Germany, Lithuania, Poland, Belgium, Hungary, Serbia, Finland, Ukraine, Switzerland, Canada, Turkey